JP2010518002A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010518002A5 JP2010518002A5 JP2009548269A JP2009548269A JP2010518002A5 JP 2010518002 A5 JP2010518002 A5 JP 2010518002A5 JP 2009548269 A JP2009548269 A JP 2009548269A JP 2009548269 A JP2009548269 A JP 2009548269A JP 2010518002 A5 JP2010518002 A5 JP 2010518002A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- bead
- pharmaceutical
- inner core
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims description 52
- 239000011324 bead Substances 0.000 claims description 43
- 238000000576 coating method Methods 0.000 claims description 35
- 239000011248 coating agent Substances 0.000 claims description 33
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 23
- 239000000654 additive Substances 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 claims description 8
- 238000013268 sustained release Methods 0.000 claims description 8
- 239000012730 sustained-release form Substances 0.000 claims description 8
- 230000000996 additive effect Effects 0.000 claims description 7
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 6
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 6
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 6
- 229960003712 propranolol Drugs 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 12
- 239000000825 pharmaceutical preparation Substances 0.000 claims 11
- 239000003795 chemical substances by application Substances 0.000 claims 9
- 239000004014 plasticizer Substances 0.000 claims 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 8
- -1 citrate ester Chemical class 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 8
- 229920001577 copolymer Polymers 0.000 claims 7
- 238000009498 subcoating Methods 0.000 claims 6
- 239000002250 absorbent Substances 0.000 claims 5
- 230000002745 absorbent Effects 0.000 claims 5
- 239000011230 binding agent Substances 0.000 claims 5
- 239000003086 colorant Substances 0.000 claims 5
- 239000003085 diluting agent Substances 0.000 claims 5
- 239000007884 disintegrant Substances 0.000 claims 5
- 239000002270 dispersing agent Substances 0.000 claims 5
- 239000003974 emollient agent Substances 0.000 claims 5
- 239000008393 encapsulating agent Substances 0.000 claims 5
- 239000000945 filler Substances 0.000 claims 5
- 239000000314 lubricant Substances 0.000 claims 5
- 239000000049 pigment Substances 0.000 claims 5
- 239000003381 stabilizer Substances 0.000 claims 5
- 239000000080 wetting agent Substances 0.000 claims 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 4
- ZFOZVQLOBQUTQQ-UHFFFAOYSA-N Tributyl citrate Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)CC(=O)OCCCC ZFOZVQLOBQUTQQ-UHFFFAOYSA-N 0.000 claims 4
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims 4
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 claims 4
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims 4
- 235000020937 fasting conditions Nutrition 0.000 claims 4
- 235000011187 glycerol Nutrition 0.000 claims 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 4
- 229920001223 polyethylene glycol Polymers 0.000 claims 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims 4
- 239000000975 dye Substances 0.000 claims 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate group Chemical group C(C(=C)C)(=O)[O-] CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 3
- 239000003961 penetration enhancing agent Substances 0.000 claims 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 2
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical group CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 claims 2
- 239000001856 Ethyl cellulose Substances 0.000 claims 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 2
- 239000000020 Nitrocellulose Substances 0.000 claims 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 2
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 239000008122 artificial sweetener Substances 0.000 claims 2
- 235000021311 artificial sweeteners Nutrition 0.000 claims 2
- WPKYZIPODULRBM-UHFFFAOYSA-N azane;prop-2-enoic acid Chemical compound N.OC(=O)C=C WPKYZIPODULRBM-UHFFFAOYSA-N 0.000 claims 2
- 229960002903 benzyl benzoate Drugs 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 229920002301 cellulose acetate Polymers 0.000 claims 2
- 229920006217 cellulose acetate butyrate Polymers 0.000 claims 2
- 238000004090 dissolution Methods 0.000 claims 2
- 239000003623 enhancer Substances 0.000 claims 2
- 229920001249 ethyl cellulose Polymers 0.000 claims 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims 2
- 235000011194 food seasoning agent Nutrition 0.000 claims 2
- 239000001087 glyceryl triacetate Substances 0.000 claims 2
- 235000013773 glyceryl triacetate Nutrition 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 2
- 239000008101 lactose Substances 0.000 claims 2
- 229920000609 methyl cellulose Polymers 0.000 claims 2
- 239000001923 methylcellulose Substances 0.000 claims 2
- 229920001220 nitrocellulos Polymers 0.000 claims 2
- 239000002357 osmotic agent Substances 0.000 claims 2
- 230000035515 penetration Effects 0.000 claims 2
- 229920000058 polyacrylate Polymers 0.000 claims 2
- 239000011118 polyvinyl acetate Substances 0.000 claims 2
- 229920002689 polyvinyl acetate Polymers 0.000 claims 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 150000005846 sugar alcohols Chemical class 0.000 claims 2
- 229960002622 triacetin Drugs 0.000 claims 2
- 239000001069 triethyl citrate Substances 0.000 claims 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims 2
- 235000013769 triethyl citrate Nutrition 0.000 claims 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 claims 1
- 239000004615 ingredient Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/701,178 | 2007-02-01 | ||
| US11/701,178 US20080187579A1 (en) | 2007-02-01 | 2007-02-01 | Extended-release dosage form |
| PCT/US2008/000926 WO2008094440A1 (en) | 2007-02-01 | 2008-01-24 | Extended-release dosage form |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014111987A Division JP5876896B2 (ja) | 2007-02-01 | 2014-05-30 | 持続放出性剤形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010518002A JP2010518002A (ja) | 2010-05-27 |
| JP2010518002A5 true JP2010518002A5 (enExample) | 2015-10-29 |
| JP5868571B2 JP5868571B2 (ja) | 2016-02-24 |
Family
ID=39496215
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009548269A Expired - Fee Related JP5868571B2 (ja) | 2007-02-01 | 2008-01-24 | 持続放出性剤形 |
| JP2014111987A Expired - Fee Related JP5876896B2 (ja) | 2007-02-01 | 2014-05-30 | 持続放出性剤形 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014111987A Expired - Fee Related JP5876896B2 (ja) | 2007-02-01 | 2014-05-30 | 持続放出性剤形 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20080187579A1 (enExample) |
| EP (1) | EP2114382A1 (enExample) |
| JP (2) | JP5868571B2 (enExample) |
| KR (1) | KR20090109117A (enExample) |
| CN (1) | CN101646422A (enExample) |
| AU (1) | AU2008211318B2 (enExample) |
| BR (1) | BRPI0807001A2 (enExample) |
| CA (1) | CA2676650C (enExample) |
| MX (1) | MX341015B (enExample) |
| NZ (1) | NZ578656A (enExample) |
| WO (1) | WO2008094440A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
| JP2013504562A (ja) * | 2009-09-17 | 2013-02-07 | カディラ・ヘルスケア・リミテッド | アルコールで誘発される用量ダンピングを低減するための医薬組成物 |
| ES2698611T3 (es) | 2012-07-12 | 2019-02-05 | SpecGx LLC | Composiciones farmacéuticas disuasorias del abuso y de liberación prolongada |
| CN104587472B (zh) * | 2014-12-31 | 2017-12-15 | 广东国方医药科技有限公司 | 一种含纳米SiO2的包衣剂及其制备方法 |
| WO2017058869A1 (en) | 2015-09-29 | 2017-04-06 | Acorda Therapeutics, Inc. | Sustained release compositions of 4-aminopyridine |
| US20170119680A1 (en) * | 2015-10-30 | 2017-05-04 | R.P. Scherer Technologies, Llc | Extended release film-coated capsules |
| KR20180108814A (ko) * | 2016-02-11 | 2018-10-04 | 바이오젠 엠에이 인코포레이티드 | 다이메틸 퓨마레이트를 포함하는 약제학적 비드 제형 |
| US10406336B2 (en) | 2016-08-03 | 2019-09-10 | Neil S. Davey | Adjustable rate drug delivery implantable device |
| CN114288273B (zh) * | 2022-02-11 | 2022-10-18 | 桂林华信制药有限公司 | 一种盐酸文拉法辛缓释胶囊及其生产工艺 |
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1561204A (en) * | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
| US4587118A (en) * | 1981-07-15 | 1986-05-06 | Key Pharmaceuticals, Inc. | Dry sustained release theophylline oral formulation |
| US4556678A (en) * | 1982-06-24 | 1985-12-03 | Key Pharmaceuticals, Inc. | Sustained release propranolol tablet |
| PH18946A (en) * | 1983-04-21 | 1985-11-14 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
| EP0164669B1 (de) * | 1984-06-13 | 1991-01-23 | Röhm Gmbh | Verfahren zum Überziehen von Arzneiformen |
| US4728512A (en) * | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
| SE455836B (sv) * | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
| US5026559A (en) * | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5683719A (en) * | 1990-11-22 | 1997-11-04 | British Technology Group Limited | Controlled release compositions |
| US5260069A (en) * | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
| US5376384A (en) * | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
| DE19504832A1 (de) * | 1995-02-14 | 1996-08-22 | Basf Ag | Feste Wirkstoff-Zubereitungen |
| IT1289160B1 (it) * | 1997-01-08 | 1998-09-29 | Jagotec Ag | Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di |
| WO2000018500A1 (de) * | 1998-09-24 | 2000-04-06 | Glatt Systemtechnik Dresden Gmbh | Einrichtung zur herstellung eines schüttfähigen produktes und verfahren zur anwendung der einrichtung |
| US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6500454B1 (en) * | 2001-10-04 | 2002-12-31 | Eurand Pharmaceuticals Ltd. | Timed, sustained release systems for propranolol |
| US9358214B2 (en) * | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| US7401157B2 (en) * | 2002-07-30 | 2008-07-15 | Brocade Communications Systems, Inc. | Combining separate infiniband subnets into virtual subnets |
| US6780003B2 (en) * | 2002-08-02 | 2004-08-24 | Mold-Masters Limited | Removable heater for a hot runner nozzle |
| GB0222612D0 (en) * | 2002-09-30 | 2002-11-06 | Univ Gent | Controlled delivery system for bioactive substances |
| US9107804B2 (en) * | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
| US8367111B2 (en) * | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
-
2007
- 2007-02-01 US US11/701,178 patent/US20080187579A1/en not_active Abandoned
-
2008
- 2008-01-24 JP JP2009548269A patent/JP5868571B2/ja not_active Expired - Fee Related
- 2008-01-24 NZ NZ578656A patent/NZ578656A/en not_active IP Right Cessation
- 2008-01-24 WO PCT/US2008/000926 patent/WO2008094440A1/en not_active Ceased
- 2008-01-24 EP EP08724778A patent/EP2114382A1/en not_active Withdrawn
- 2008-01-24 CA CA2676650A patent/CA2676650C/en not_active Expired - Fee Related
- 2008-01-24 BR BRPI0807001-6A2A patent/BRPI0807001A2/pt not_active Application Discontinuation
- 2008-01-24 KR KR1020097017971A patent/KR20090109117A/ko not_active Ceased
- 2008-01-24 AU AU2008211318A patent/AU2008211318B2/en not_active Ceased
- 2008-01-24 MX MX2009008197A patent/MX341015B/es active IP Right Grant
- 2008-01-24 CN CN200880009949A patent/CN101646422A/zh active Pending
-
2010
- 2010-12-23 US US12/977,713 patent/US20110123613A1/en not_active Abandoned
-
2014
- 2014-05-30 JP JP2014111987A patent/JP5876896B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-25 US US15/218,620 patent/US20170049724A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010518002A5 (enExample) | ||
| US11147772B2 (en) | Timed, pulsatile release systems | |
| JP2014208655A5 (enExample) | ||
| JP5876896B2 (ja) | 持続放出性剤形 | |
| JP2012153724A5 (enExample) | ||
| US10213389B2 (en) | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | |
| US20100008987A1 (en) | Modified Release Pharmaceutical Composition of Bupropion Hydrochloride | |
| RU2013150254A (ru) | Пероральный твердый препарат комбинированного противотуберкулезного лекарственного средства и способ его получения | |
| TWI434682B (zh) | 用以製備控制釋放口服劑型的配方及方法 | |
| US20080193524A1 (en) | Extended Release Venlafaxine Compositions | |
| US9480681B2 (en) | Controlled release formulations of nisoldipine | |
| AU2013273835B2 (en) | Timed, pulsatile release systems | |
| TW201609196A (zh) | 控制釋放製劑及其製備方法 | |
| JP2005510449A (ja) | 改良型制御放出経口剤形 | |
| HK1108116B (en) | Timed, pulsatile release systems | |
| HK1189799A (en) | Timed, pulsatile release systems |